Yahoo Web Search

Search results

1. • Scientists find 'Goldilocks' binding strength determines anti-cancer T-cell efficacy and fate

     Medical Xpress· 22 hours ago

     St. Jude Children's Research Hospital scientists found that how tight a parental T cell grabs a cancer protein determines if its daughter cells will be anti-cancer effectors or exhausted. T ...

2. • 

     New immunotherapy could treat cancer in the bone

     Medical Xpress· 2 days ago

     Osteosarcoma is the most common bone cancer in teenagers but is still relatively rare, with around 160 new cases each year in the UK. Meanwhile, more...

3. • 

     All over the body: Here are the key clinical trials from Bay Area firms - San Francisco Business...

     The Business Journals· 7 days ago

     Since the turn of the millennium, Bay Area organizations and researchers have launched more than 300...

4. • Undiscovered Stocks on the Verge of a Breakout: 3 Names to Know Now

     InvestorPlace· 1 day ago

     The following stocks represent companies that have good fundamentals or a big addressable market for growth. Ibotta (NYSE:IBTA) stock is a relatively new listing and has remained sideways in ...

5. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 7 days ago

     Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced today that ...

6. • Here's how you can help a Virginia boy battling leukemia for a second time

     CBS 6 Richmond· 14 hours ago

     Cayden Addison is 7 years old, and according to his mom, he's a sweet and loving boy who loves food. Cayden is also battling his second diagnosis of a rare form of leukemia. Cayden's mom, Courtney ...

7. • Penn Medicine named LGBTQ+ Health Care Leader by H | Newswise

     Newswise· 3 days ago

     Six hospitals in the University of Pennsylvania Health System (UPHS) earned perfect scores as part of Penn Medicine once again being named a 2024 LGBTQ+ He

8. • Penn Medicine Brings Free 3D Mammograms and Health | Newswise

     Newswise· 3 days ago

     Penn Medicine will once again join with community partners and Siemens Healthineers to host a free mammogram clinic and community health fair in June, giving the West Philadelphia and Upper ...

9. • Cancer researchers discover optimal cancer-killing T cells

     Medical Xpress· 3 days ago

     T cell-based immunotherapy has tremendous value to fight, and often eliminate, cancer. The strategy activates a patient's immune system and engineers a patient's own T cells to recognize, attack ...

10. • Small Business - Shelby County Reporter | Shelby County Reporter

      The Shelby County Reporter· 4 days ago

      NEW YORK, May 27, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today